Drug-Induced Torsade de Pointes. From Molecular Biology to Bedside.
Open Access
- 1 January 2000
- journal article
- review article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 83 (1), 1-19
- https://doi.org/10.1254/jjp.83.1
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 140 references indexed in Scilit:
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonatesAmerican Heart Journal, 1997
- Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA, 1993
- Torsades de pointes with Almokalant, a new class III antiarrhythmic drugAmerican Heart Journal, 1993
- Cocaine-induced torsades de pointes in a patient with the idiopathic long QT syndromeAmerican Heart Journal, 1990
- Torsade de pointes associated with elevated N-acetylprocainamide levelsAmerican Heart Journal, 1985
- QT interval prolongation associated with anthracycline cardiotoxicityThe Journal of Pediatrics, 1984
- Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patientsJournal of the American College of Cardiology, 1983
- Malignant ventricular tachyarrhythmias associated with the use of encainideAmerican Heart Journal, 1981
- Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval.Circulation, 1979